Terilyn J. Monroe sold $7.6M of GH
Chief People Officer at Guardant Health, Inc.. 46,300 shares at an average of $165.12, traded Aug 12, 2026, filed Aug 13, 2026.
Score components
- +15RoleOfficer
- +25Trade size$7.6M at market
- +20Share of holdings soldSold 67% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001652956-26-000018, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | MOption exercise Common Stock | +32,288 | $20.14 | $650k | 55,267 | Aug 13, 2026 |
| Aug 12, 2026 | MOption exercise Common Stock | +14,012 | $28.61 | $401k | 69,279 | Aug 13, 2026 |
| Aug 12, 2026 | SOpen-market sale Common Stock | -3,704 | $163.41 | $605k | 65,575 | Aug 13, 2026 |
| Aug 12, 2026 | SOpen-market sale Common Stock | -9,934 | $164.27 | $1.6M | 55,641 | Aug 13, 2026 |
| Aug 12, 2026 | SOpen-market sale Common Stock | -19,014 | $165.16 | $3.1M | 36,627 | Aug 13, 2026 |
| Aug 12, 2026 | SOpen-market sale Common Stock | -13,248 | $166.11 | $2.2M | 23,379 | Aug 13, 2026 |
| Aug 12, 2026 | SOpen-market sale Common Stock | -400 | $167.92 | $67k | 22,979 | Aug 13, 2026 |
| Aug 12, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -32,288 | $0.00 | $0 | 10,916 | Aug 13, 2026 |
| Aug 12, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -14,012 | $0.00 | $0 | 18,615 | Aug 13, 2026 |
Related signals
Other insiders at Guardant Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Guardant Health, Inc. | Alex M Azar II director | $145k 826 shares | -50% | |
| 55Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $1.4M 7,738 shares | -10% | |
| 65Notable | Guardant Health, Inc. | Steve E. Krognes director | $1.2M 6,674 shares | -46% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $20k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $632k 4,000 shares | -9% | |
| 85Strong | Guardant Health, Inc. | AmirAli Talasaz Co-Chief Executive Officer | $6.3M 37,500 shares | -50% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $18k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Chris Freeman Chief Commercial Officer | $11M 63,605 shares | -49% | |
| 39Weak | Guardant Health, Inc. | Medina Manuel Hidalgo director | $279k 1,700 shares | -27% | |
| 60Notable | Guardant Health, Inc. | Ian T Clark director | $2.3M 14,180 shares | -83% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.